Journal of Medical Economics, Volume 23, Issue 12 (2020)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 23, Issue 12 (2020)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Volume 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Vol 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs

CARDIOVASCULAR MEDICINE: Editorial

Editorial
Cost-effectiveness of cardiac resynchronization therapy
Cristian Martignani, Giulia Massaro, Igor Diemberger, Matteo Ziacchi, Andrea Angeletti, Nazzareno Galiè & Mauro Biffi
Pages: 1375-1378
Published online: 21 Oct 2020
First Page PreviewforCost-effectiveness of cardiac resynchronization therapy | Full Text | References | PDF (320.4 KB) | EPUB
  • 1464 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

CARDIOVASCULAR MEDICINE: Original Research

Article
Comparison of hospital length of stay of acute ischemic stroke patients with non-valvular atrial fibrillation started on rivaroxaban or warfarin treatment during hospitalization
Takeshi Yamashita, Thomas Laurent, Masaharu Kato, Nariaki Yoshihara & Fumiko Ono
Pages: 1379-1388
Published online: 08 Oct 2020
AbstractforComparison of hospital length of stay of acute ischemic stroke patients with non-valvular atrial fibrillation started on rivaroxaban or warfarin treatment during hospitalization | Full Text | References | PDF (1.7 MB) | EPUB | Supplemental
  • 2658 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Utilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA
Steven Deitelzweig, Amol D. Dhamane, Manuela Di Fusco, Cristina Russ, Lisa Rosenblatt, Melissa Lingohr-Smith & Jay Lin
Pages: 1389-1400
Published online: 19 Oct 2020
AbstractforUtilization of anticoagulants and predictors of treatment among hospitalized patients with atrial fibrillation in the USA | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 1665 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial
Gerasimos Filippatos, Xiaoxiao Lu, Stelios I. Tsintzos, Michael R. Gold, Wilfried Mullens, David Birnie, Ahmad S. Hersi, Kengo Kusano, Christophe Leclercq, Dedra H. Fagan & Bruce L. Wilkoff
Pages: 1401-1408
Published online: 28 Oct 2020
AbstractforEconomic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1282 Views
  • 1 CrossRef citations
  • 0Altmetric
Open Access
Article
Major bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants
Gregory J. Fermann, Belinda Lovelace, Mary J. Christoph, Melissa Lingohr-Smith, Jay Lin & Steven B. Deitelzweig
Pages: 1409-1417
Published online: 27 Oct 2020
AbstractforMajor bleed costs of atrial fibrillation patients treated with factor Xa inhibitor anticoagulants | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1348 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Budget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain
Juan F. Delgado, Juan Oliva, Álvaro González-Franco, Jose María Cepeda, Jose Ángel García-García, Almudena González-Domínguez, Albert Garcia-Casanovas, Silvia Jiménez Merino & Josep Comín-Colet
Pages: 1418-1424
Published online: 30 Oct 2020
AbstractforBudget impact of ferric carboxymaltose treatment in patients with chronic heart failure and iron deficiency in Spain | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 2379 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
An analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK
Judith Shore, Joel Russell, Lutz Frankenstein, Pascal Candolfi & Michelle Green
Pages: 1425-1434
Published online: 11 Dec 2020
AbstractforAn analysis of the cost-effectiveness of transcatheter mitral valve repair for people with secondary mitral valve regurgitation in the UK | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2810 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

GENETIC DISEASE: Original Research

Article
Hospital incidence, management and direct cost of osteogenesis imperfecta in Spain: a retrospective database analysis
Josep Darbà & Alicia Marsà
Pages: 1435-1440
Published online: 21 Oct 2020
AbstractforHospital incidence, management and direct cost of osteogenesis imperfecta in Spain: a retrospective database analysis | Full Text | References | PDF (928.5 KB) | EPUB
  • 1906 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Cost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP)
Samira Massachi, Josh Epstein, Julie Hurd & Herbert L. Bonkovsky
Pages: 1441-1449
Published online: 27 Oct 2020
AbstractforCost savings with hemin versus givosiran for the treatment of patients with acute intermittent porphyria (AIP) | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 4720 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access

HEALTH FINANCING: Original Research

Article
Alternative payment models and innovation: a case study of US health system adoption of a sacubitril/valsartan to treat acute decompensated heart failure
Jason Shafrin, Elmar R. Aliyev, Michelle Brauer, Siyeon Park & Xian Shen
Pages: 1450-1460
Published online: 07 Oct 2020
AbstractforAlternative payment models and innovation: a case study of US health system adoption of a sacubitril/valsartan to treat acute decompensated heart failure | Full Text | References | PDF (1.1 MB) | EPUB
  • 1454 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

HEALTH FINANCING: Article Commentary

Article Commentary
Iran, sanctions, and the COVID-19 crisis
Amir Abdoli
Pages: 1461-1465
Published online: 16 Dec 2020
AbstractforIran, sanctions, and the COVID-19 crisis | Full Text | References | PDF (943.7 KB) | EPUB | Supplemental
  • 9704 Views
  • 31 CrossRef citations
  • 0Altmetric
Open Access

HEMATOLOGY: Original Research

Article
Cost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv
Karen MacDonald, Ali McBride, Neda Alrawashdh & Ivo Abraham
Pages: 1466-1476
Published online: 24 Oct 2020
AbstractforCost-efficiency and expanded access of prophylaxis for chemotherapy-induced (febrile) neutropenia: economic simulation analysis for the US of conversion from reference pegfilgrastim to biosimilar pegfilgrastim-cbqv | Full Text | References | PDF (978.8 KB) | EPUB
  • 2175 Views
  • 13 CrossRef citations
  • 0Altmetric
Open Access
Article
Epidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain at the hospital level: a claims database analysis
Alicia Marsà, Meritxell Ascanio, Javier Diaz-García & Josep Darbà
Pages: 1477-1484
Published online: 02 Nov 2020
AbstractforEpidemiology, management, and economic impact of acute myeloid leukemia and myelodysplastic syndrome in Spain at the hospital level: a claims database analysis | Full Text | References | PDF (1.2 MB) | EPUB
  • 4548 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong
Thomas Sau-Yan Chan, Sally Shuk-Yee Cheng, Wei-Ting Chen, Danny Chung Hsu, Rene Wing-Yan Chau, Suk Hyun Kang, Adnan Alsumali & Yok-Lam Kwong
Pages: 1485-1492
Published online: 12 Nov 2020
AbstractforCost-effectiveness of letermovir as cytomegalovirus prophylaxis in adult recipients of allogeneic hematopoietic stem cell transplantation in Hong Kong | Full Text | References | PDF (1.1 MB) | EPUB
  • 3169 Views
  • 9 CrossRef citations
  • 0Altmetric
Open Access

HEMATOLOGY: Review Article

Review Article
A systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A
Lukas Graf, Songkai Yan, Ming-Ching Shen & Vinod Balasa
Pages: 1493-1498
Published online: 16 Oct 2020
AbstractforA systematic review evaluating the efficacy and factor consumption of long-acting recombinant factor VIII products for the prophylactic treatment of hemophilia A | Full Text | References | PDF (740 KB) | EPUB
  • 3866 Views
  • 5 CrossRef citations
  • 0Altmetric
Open Access

IMMUNOLOGY: Letter to the Editor

Letter
Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–649
Brad Glick, Annie Guerin, Rajeev Ayyagari, Tina Lin, Abby Jacobson, George Joseph & Leon Kircik
Pages: 1499-1500
Published online: 06 Nov 2020
CitationforRe: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–649 | Full Text | References | PDF (409.9 KB) | EPUB
  • 1294 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Reply
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–649
Jashin J. Wu, Jes B. Hansen, Dharm S. Patel, Nanna Nyholm, Karen A. Veverka & Andrine R. Swensen
Pages: 1501-1502
Published online: 06 Nov 2020
CitationforReply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641–649 | Full Text | References | PDF (189.3 KB) | EPUB
  • 1093 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

METHODS AND MODELING: Original Research

Article
A US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome
Yan Wang, Karissa Johnston, Evan Popoff, Karl-Johan Myren, Antoinette Cheung, Claudio Faria & Ioannis Tomazos
Pages: 1503-1515
Published online: 10 Nov 2020
AbstractforA US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 5693 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access
Article
Early health economic modelling for a treatment candidate in hidradenitis suppurativa
Damon Willems, Mata Charokopou, Silvia M. A. A. Evers & Mickaël Hiligsmann
Pages: 1516-1524
Published online: 09 Nov 2020
AbstractforEarly health economic modelling for a treatment candidate in hidradenitis suppurativa | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 3315 Views
  • 4 CrossRef citations
  • 0Altmetric
Open Access

NEUROLOGY: Original Research

Article
Cost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada
Hamid Reza Nakhaipour, Umakanth Vudumula, Vivek Khurana, Guillaume Sébire, Jean K. Mah, Daniela Pohl, Robyn Schecter & Nicholas Adlard
Pages: 1525-1533
Published online: 12 Nov 2020
AbstractforCost-effectiveness of fingolimod versus interferon-β1a for the treatment of pediatric-onset multiple sclerosis in Canada | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1983 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access

ONCOLOGY: Original Research

Article
Cost-effectiveness of Lutetium [177Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France
O. Leeuwenkamp, J. Smith-Palmer, R. Ortiz, A. Werner, W. Valentine, M. Blachier & T. Walter
Pages: 1534-1541
Published online: 16 Oct 2020
AbstractforCost-effectiveness of Lutetium [177Lu] oxodotreotide versus best supportive care with octreotide in patients with midgut neuroendocrine tumors in France | Full Text | References | PDF (906.6 KB) | EPUB | Supplemental
  • 1894 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Article
Economic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan
Victoria Federico Paly, Yusuke Hikichi, Timothy Baker, Eijun Itakura, Nisha Chandran & James Harrison
Pages: 1542-1552
Published online: 28 Oct 2020
AbstractforEconomic evaluation of nivolumab combined with ipilimumab in the first-line treatment of advanced melanoma in Japan | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 3167 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access
Article
Economic burden for retinoblastoma patients in China
Yuchen Zhou, Siyu Cai, Mei Jin, Chiyi Jiang, Na Xu, Chao Duan, Xiaoxia Peng, Junyang Zhao & Xiaoli Ma
Pages: 1553-1557
Published online: 27 Oct 2020
AbstractforEconomic burden for retinoblastoma patients in China | Full Text | References | PDF (619.6 KB) | EPUB
  • 1234 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Article
Changes in mortality associated with cancer drug approvals in the United States from 2000 to 2016
Joanna P. MacEwan, Syvart Dennen, Rebecca Kee, Farzad Ali, Jason Shafrin & Katharine Batt
Pages: 1558-1569
Published online: 09 Nov 2020
AbstractforChanges in mortality associated with cancer drug approvals in the United States from 2000 to 2016 | Full Text | References | PDF (2 MB) | EPUB | Supplemental
  • 5070 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access
Article
Factors associated with humanistic burden and indirect cost among patients with cancer in Japan
Shinya Ohno, Yirong Chen, Hiroyuki Sakamaki, Naoki Matsumaru & Katsura Tsukamoto
Pages: 1570-1578
Published online: 05 Nov 2020
AbstractforFactors associated with humanistic burden and indirect cost among patients with cancer in Japan | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 1314 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
An updated cost-effectiveness analysis of pazopanib versus sunitinib as first-line treatment for locally advanced or metastatic renal cell carcinoma in Italy
Stefano Capri, Camillo Porta, Claudia Condorelli, Eleonora Premoli, Ankur Khare, Manik Kalra, Niraj Modi & Barbara Ratto
Pages: 1579-1587
Published online: 05 Nov 2020
AbstractforAn updated cost-effectiveness analysis of pazopanib versus sunitinib as first-line treatment for locally advanced or metastatic renal cell carcinoma in Italy | Full Text | References | PDF (1.1 MB) | EPUB
  • 1478 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
A cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK
V. K. Brennan, F. Colaone, S. Shergill & R. F. Pollock
Pages: 1588-1597
Published online: 02 Dec 2020
AbstractforA cost-utility analysis of SIR-Spheres Y-90 resin microspheres versus best supportive care in the treatment of unresectable metastatic colorectal cancer refractory to chemotherapy in the UK | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 2102 Views
  • 3 CrossRef citations
  • 0Altmetric
Open Access

ORTHOPAEDICS: Original Research

Article
Economic burden of subsequent fracture in osteoporosis patients in South Korea
Jae-A Park, Jin Hyun Nam, Sung-Hyun Hong, Yoon-Bo Shim, Jihae Jeong & Ju-Young Shin
Pages: 1598-1605
Published online: 02 Nov 2020
AbstractforEconomic burden of subsequent fracture in osteoporosis patients in South Korea | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 1222 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

REAL WORLD EVIDENCE: Editorial

Editorial
Key patient related factors in the management of inflammatory bowel disease
Eleonora Allocati & Brian Godman
Pages: 1606-1609
Published online: 19 Nov 2020
First Page PreviewforKey patient related factors in the management of inflammatory bowel disease | Full Text | References | PDF (446 KB) | EPUB
  • 928 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

REAL WORLD EVIDENCE: Original Research

Article
Hospitalization charges for extremely preterm infants: a ten-year analysis in Shanghai, China
Zhicheng Zhu, Jin Wang, Chao Chen & Jianguo Zhou
Pages: 1610-1617
Published online: 02 Nov 2020
AbstractforHospitalization charges for extremely preterm infants: a ten-year analysis in Shanghai, China | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 1089 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

REAL WORLD EVIDENCE: Article Commentary

Article Commentary
Using electronic health record data to identify comparator populations for comparative effectiveness research
Scott D. Ramsey, Blythe J. Adamson, Xiaoliang Wang, Danielle Bargo, Shrujal S. Baxi, Shuhag Ghosh & Neal J. Meropol
Pages: 1618-1622
Published online: 10 Nov 2020
AbstractforUsing electronic health record data to identify comparator populations for comparative effectiveness research | Full Text | References | PDF (494.8 KB) | EPUB
  • 3246 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access

RENAL DISEASE: Original Research

Article
Chronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011–2017)
Josep Darbà & Alicia Marsà
Pages: 1623-1629
Published online: 27 Oct 2020
AbstractforChronic kidney disease in Spain: analysis of patient characteristics, incidence and direct medical costs (2011–2017) | Full Text | References | PDF (899.4 KB) | EPUB
  • 2746 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

RESPIRATORY MEDICINE: Original Research

Article
Cost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in China
Xiaoling Wang, Honghao Fang, Kunling Shen, Tianyi Liu, Jipan Xie, Yuantao Liu, Peibei Wu, Yilin Chen, Jia Zhong, Eric Wu, Wei Zhou & Bin Wu
Pages: 1630-1639
Published online: 14 Oct 2020
AbstractforCost-effectiveness analysis of double low-dose budesonide and low-dose budesonide plus montelukast among pediatric patients with persistent asthma receiving Step 3 treatment in China | Full Text | References | PDF (1.1 MB) | EPUB
  • 1648 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Article
Updated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK
Omendra Narayan, Anthony Bentley, Katie Mowbray, Monika Hermansson, Dominic Pivonka, Eric Ngonga Kemadjou & Jonathan Belsey
Pages: 1640-1652
Published online: 27 Oct 2020
AbstractforUpdated cost-effectiveness analysis of palivizumab (Synagis) for the prophylaxis of respiratory syncytial virus in infant populations in the UK | Full Text | References | PDF (2 MB) | EPUB
  • 4232 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

VACCINES: Original Research

Article
Health and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States
Tianyan Hu, Thomas Weiss, Kwame Owusu-Edusei & Tanaz Petigara
Pages: 1653-1660
Published online: 05 Nov 2020
AbstractforHealth and economic burden associated with 15-valent pneumococcal conjugate vaccine serotypes in children in the United States | Full Text | References | PDF (877.7 KB) | EPUB
  • 2340 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access

Explore articles

Explore the most recently published articles

The efficiency of TAVI in intermediate and low-risk Japanese patients.
Panagiotis Petrou
Editorial | Published online: 25 May 2024
Open Access
Cost-effectiveness of empagliflozin as add-on to standard of care for chronic kidney disease management in the United Kingdom
Mafalda Ramos et al.
Article | Published online: 17 May 2024
Open Access
Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening
John B. Kisiel et al.
Article | Published online: 13 May 2024
Open Access
Balancing innovation and ethics in AI governance for health technology assessment
João L. Carapinha et al.
Editorial | Published online: 13 May 2024
Open Access
View all latest articles